Global Drugs for Non-small Cell Lung Cancer Market Size, Status and Forecast 2022

Global Drugs for Non-small Cell Lung Cancer Market Size, Status and Forecast 2022

1 Industry Overview of Drugs for Non-small Cell Lung Cancer

1.1 Drugs for Non-small Cell Lung Cancer Market Overview

1.1.1 Drugs for Non-small Cell Lung Cancer Product Scope

1.1.2 Market Status and Outlook

1.2 Global Drugs for Non-small Cell Lung Cancer Market Size and Analysis by Regions

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Drugs for Non-small Cell Lung Cancer Market by Type

1.3.1 Radiofrequency Ablation (RFA)

1.3.2 Radiation Therapy

1.3.3 Chemotherapy

1.3.4 Targeted Therapies

1.3.5 Immunotherapy

1.4 Drugs for Non-small Cell Lung Cancer Market by End Users/Application

1.4.1 Hospitals

1.4.2 Clinics

1.4.3 Other

2 Global Drugs for Non-small Cell Lung Cancer Competition Analysis by Players

2.1 Drugs for Non-small Cell Lung Cancer Market Size (Value) by Players (2016 and 2017)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 Bristol-Myers Squibb

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.1.5 Recent Developments

3.2 GlaxoSmithKline

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.2.5 Recent Developments

3.3 Menarini

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.3.5 Recent Developments

3.4 Sanofi

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.4.5 Recent Developments

3.5 Ziopharm Oncology

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.5.5 Recent Developments

3.6 Alchemia

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.6.5 Recent Developments

3.7 Amgen

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.7.5 Recent Developments

3.8 Apotex

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.8.5 Recent Developments

3.9 BioMarin Pharmaceutical

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.9.5 Recent Developments

3.10 CellAct Pharma

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Drugs for Non-small Cell Lung Cancer Revenue (Value) (2012-2017)

3.10.5 Recent Developments

3.11 Cerulean Pharma

3.12 Cipla

3.13 Cornerstone Pharmaceuticals

3.14 Curis

3.15 CytRx

3.16 Eli Lilly

3.17 Exelixis

3.18 Fresenius Kabi

3.19 Genentech

3.20 Hikma Pharmaceuticals

3.21 Hospira

3.22 Intas Pharmaceuticals

3.23 Karyopharm Therapeutics

3.24 Kyowa Hakko Kirin

3.25 Ligand Pharmaceuticals

4 Global Drugs for Non-small Cell Lung Cancer Market Size by Type and Application (2012-2017)

4.1 Global Drugs for Non-small Cell Lung Cancer Market Size by Type (2012-2017)

4.2 Global Drugs for Non-small Cell Lung Cancer Market Size by Application (2012-2017)

4.3 Potential Application of Drugs for Non-small Cell Lung Cancer in Future

4.4 Top Consumer/End Users of Drugs for Non-small Cell Lung Cancer

5 United States Drugs for Non-small Cell Lung Cancer Development Status and Outlook

5.1 United States Drugs for Non-small Cell Lung Cancer Market Size (2012-2017)

5.2 United States Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2016 and 2017)

6 EU Drugs for Non-small Cell Lung Cancer Development Status and Outlook

6.1 EU Drugs for Non-small Cell Lung Cancer Market Size (2012-2017)

6.2 EU Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2016 and 2017)

7 Japan Drugs for Non-small Cell Lung Cancer Development Status and Outlook

7.1 Japan Drugs for Non-small Cell Lung Cancer Market Size (2012-2017)

7.2 Japan Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2016 and 2017)

8 China Drugs for Non-small Cell Lung Cancer Development Status and Outlook

8.1 China Drugs for Non-small Cell Lung Cancer Market Size (2012-2017)

8.2 China Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2016 and 2017)

9 India Drugs for Non-small Cell Lung Cancer Development Status and Outlook

9.1 India Drugs for Non-small Cell Lung Cancer Market Size (2012-2017)

9.2 India Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Drugs for Non-small Cell Lung Cancer Development Status and Outlook

10.1 Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (2012-2017)

10.2 Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)

11.1 Global Drugs for Non-small Cell Lung Cancer Market Size (Value) by Regions (2017-2022)

11.1.1 United States Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2017-2022)

11.1.2 EU Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2017-2022)

11.1.3 Japan Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2017-2022)

11.1.4 China Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2017-2022)

11.1.5 India Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2017-2022)

11.1.6 Southeast Asia Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate (2017-2022)

11.2 Global Drugs for Non-small Cell Lung Cancer Market Size (Value) by Type (2017-2022)

11.3 Global Drugs for Non-small Cell Lung Cancer Market Size by Application (2017-2022)

12 Drugs for Non-small Cell Lung Cancer Market Dynamics

12.1 Drugs for Non-small Cell Lung Cancer Market Opportunities

12.2 Drugs for Non-small Cell Lung Cancer Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Drugs for Non-small Cell Lung Cancer Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Drugs for Non-small Cell Lung Cancer Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

Figure Drugs for Non-small Cell Lung Cancer Product Scope

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) (2012-2017)

Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Drugs for Non-small Cell Lung Cancer Market Share by Regions in 2016

Figure United States Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure EU Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Japan Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure China Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure India Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Drugs for Non-small Cell Lung Cancer Market Share by Type in 2016

Figure Radiofrequency Ablation (RFA) Market Size (Million USD) and Growth Rate (2012-2017)

Figure Radiation Therapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Chemotherapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Targeted Therapies Market Size (Million USD) and Growth Rate (2012-2017)

Figure Immunotherapy Market Size (Million USD) and Growth Rate (2012-2017)

Figure Global Drugs for Non-small Cell Lung Cancer Market Share by Application in 2016

Table Key Downstream Customer in Hospitals

Figure Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)

Table Key Downstream Customer in Clinics

Figure Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate in Clinics (2012-2017)

Table Key Downstream Customer in Other

Figure Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate in Other (2012-2017)

Table Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2016 and 2017)

Figure Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2016

Figure Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017

Table Bristol-Myers Squibb Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)

Figure Bristol-Myers Squibb Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table GlaxoSmithKline Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)

Figure GlaxoSmithKline Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Menarini Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Menarini (2012-2017)

Figure Menarini Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Sanofi Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Sanofi (2012-2017)

Figure Sanofi Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Ziopharm Oncology Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Ziopharm Oncology (2012-2017)

Figure Ziopharm Oncology Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Alchemia Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Alchemia (2012-2017)

Figure Alchemia Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Amgen Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Amgen (2012-2017)

Figure Amgen Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Apotex Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Apotex (2012-2017)

Figure Apotex Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table BioMarin Pharmaceutical Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of BioMarin Pharmaceutical (2012-2017)

Figure BioMarin Pharmaceutical Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table CellAct Pharma Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of CellAct Pharma (2012-2017)

Figure CellAct Pharma Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Cerulean Pharma Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Cerulean Pharma (2012-2017)

Figure Cerulean Pharma Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Cipla Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Cipla (2012-2017)

Figure Cipla Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Cornerstone Pharmaceuticals Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Cornerstone Pharmaceuticals (2012-2017)

Figure Cornerstone Pharmaceuticals Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Curis Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Curis (2012-2017)

Figure Curis Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table CytRx Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of CytRx (2012-2017)

Figure CytRx Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Eli Lilly Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Eli Lilly (2012-2017)

Figure Eli Lilly Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Exelixis Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Exelixis (2012-2017)

Figure Exelixis Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Fresenius Kabi Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Fresenius Kabi (2012-2017)

Figure Fresenius Kabi Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Genentech Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Genentech (2012-2017)

Figure Genentech Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Hikma Pharmaceuticals Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Hikma Pharmaceuticals (2012-2017)

Figure Hikma Pharmaceuticals Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Hospira Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Hospira (2012-2017)

Figure Hospira Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Intas Pharmaceuticals Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Intas Pharmaceuticals (2012-2017)

Figure Intas Pharmaceuticals Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Karyopharm Therapeutics Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Karyopharm Therapeutics (2012-2017)

Figure Karyopharm Therapeutics Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Kyowa Hakko Kirin Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Kyowa Hakko Kirin (2012-2017)

Figure Kyowa Hakko Kirin Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Ligand Pharmaceuticals Basic Information List

Table Drugs for Non-small Cell Lung Cancer Business Revenue (Million USD) of Ligand Pharmaceuticals (2012-2017)

Figure Ligand Pharmaceuticals Drugs for Non-small Cell Lung Cancer Business Revenue Market Share in 2016

Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Type (2012-2017)

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2012

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2013

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2014

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2015

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2016

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2017

Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application (2012-2017)

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2012

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2013

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2014

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2015

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2016

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2017

Table Top Consumer/End Users of Drugs for Non-small Cell Lung Cancer

Figure United States Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table United States Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2012-2017)

Figure United States Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2016

Figure United States Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017

Figure EU Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table EU Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2012-2017)

Figure EU Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2016

Figure EU Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017

Figure Japan Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Japan Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2012-2017)

Figure Japan Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2016

Figure Japan Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017

Figure China Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table China Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2012-2017)

Figure China Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2016

Figure China Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017

Figure India Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table India Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2012-2017)

Figure India Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2016

Figure India Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017

Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Players (2012-2017)

Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2016

Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Market Size Share by Players in 2017

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Regions (2017-2022)

Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Regions (2017-2022)

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Regions in 2017

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Regions in 2022

Figure United States Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2017-2022)

Figure EU Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2017-2022)

Figure Japan Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2017-2022)

Figure China Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2017-2022)

Figure India Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2017-2022)

Figure Southeast Asia Drugs for Non-small Cell Lung Cancer Revenue (Million USD) and Growth Rate (2017-2022)

Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Type (2017-2022)

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2017

Figure Global Drugs for Non-small Cell Lung Cancer Market Size Share by Type in 2022

Table Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application (2017-2022)

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2017

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) by Application in 2022